Phase I clinical trial of HC-1119: A deuterated form of enzalutamide. Li X, Cheng K, Li X, Zhou Y, et al. Int J Cancer 2021;149:1473-1482.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li X, Cheng K, Li X, Zhou Y, et al. Phase I clinical trial of HC-1119: A deuterated form of enzalutamide. Int J Cancer 2021;149:1473-1482.
PMID: 34109624